Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Decisions of the Repeated Annual General Meeting of Shareholders of AB “Novaturas”
-
Akanda Corp. Regains Compliance with Nasdaq Periodic Filing Requirement
-
MAX Closes Debt and Option Agreements with Bolt Metals for Its Florália High-Purity Iron Property in Brazil
-
Triple Flag Announces US$440 Million Gold Stream on the Ravenswood Gold Mine and Increases 2030 Outlook
-
Cogent Biosciences Announces Preclinical Data from Novel JAK2 V617F Inhibitor at the 2026 European Hematology Association (EHA) Congress
-
Inman Unveils Reimagined Event Experience Ahead of Inman Connect San Diego 2026
-
Cherry On Top: The Beachwaver Co. Makes the Creator PR Package Shoppable With Kelsey Martinez Collaboration
-
Silvercorp reports a Mineral Reserve increase of 50% in tonnes and 20% in silver ounces for the Ying Mining District
-
Insulin Resistance Explained in HelloNation Article Featuring Health Expert Dr. Karen Jerome-Zapadka
-
Pixelworks and CINITY Partner to Expand TrueCut Motion Ecosystem
-
Xthings and ULTRALOQ to Showcase Dealer-Ready Smart Access Solutions at ALOA 2026
-
OPENLANE Appoints Kelly Tuminelli and David Hult to Board of Directors
-
Everlert, Inc. (OTC: EVLI), Announces Discussions Regards Potential Acquisition of the Rimrock Copper-Gold Project in Nevada
-
Research Collaboration Secured to Evaluate AI-Driven Cardiac Risk Stratification in Cancer Patients
-
Wilmington NC Decluttering Tips Explained In HelloNation Article Featuring Organizing Expert Kristin Roser
-
Gan & Lee Pharmaceuticals Achieves Significant Progress in Its Dual Pipeline for Metabolic Diseases -- Weekly Insulin Ludefen (GZR4) Meets Primary Endpoint in Phase III Clinical Trial in China; Bo
-
Trading Technologies Wins Best Sell-Side OMS at TradingTech Insight Awards USA 2026
-
Hartwig Medical Foundation and Ultima Genomics Expand Collaboration to Advance Whole-Genome Sequencing in Oncology Care
-
Jazz Pharmaceuticals Provides Update on Zepzelca® (lurbinectedin) Phase 3 LAGOON Trial in Second-Line Small Cell Lung Cancer
-
MAX Power Announces Special Meeting of Shareholders and Completion of Warrant Exercise for Total Proceeds of $3.75 Million
-
Kalaris to Present at Clinical Trials at the Summit 2026
-
ARQA's AI Innovation and CEO Leadership Recognized in 2026 Wealthies Awards
-
Cunard Invites Travelers to Win an Experience On Queen Mary 2's Historic 450th Transatlantic Crossing
-
Independent Bank Corporation Announces Regulatory Approvals to Acquire HCB Financial Corp. and Highpoint Community Bank
-
M Group Strategic Communications Clients Recognized in Fortune's Inaugural Crypto 100 And Crypto Innovators Rankings
-
BRAEMAR HOTELS & RESORTS ANNOUNCES CONCLUSION OF STRATEGIC REVIEW PROCESS AND PLAN TO BECOME A SELF-MANAGED REIT AND REMAIN PUBLICLY TRADED
-
SOSNA Brings 20+ Years of Full-Service Renovation Experience to Toronto Homeowners
-
Cogent Biosciences Announces Detailed Data from APEX Pivotal Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis at the 2026 European Hematology Association (EHA) Congress
-
Genesis Unveils Magma GT3 Concept and Outlines Next-Decade Vision at 24 Hours of Le Mans Debut
-
SpaceX Employees Could Buy 2 in 5 San Antonio Homes With Their IPO Windfall
-
Cushman & Wakefield Advises Ericsson On Record 1 Million-Square-Foot HQ Transaction
-
CEL-SCI and Saudi Amarox to Conduct Signing Ceremony at BIO 2026 for Strategic Agreement to Advance Commercialization and Distribution of Multikine® in Saudi Arabia
-
BusRight Proudly Honors Texas Special Education School Bus Driver With Inaugural ‘Behind the Wheel’ Award
-
Momentus Announces Pricing of a $25 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules with New and Existing Fundamental Institutional Investors
-
Rezolve Ai Board Moves to Authorize Capital Reduction and Up to $300 Million Share Repurchase Program
-
Zodiac Partners II, LLC Reaffirms its Previously Announced $46 million Tender Offer to Acquire Destination XL Group, Inc. for $0.82 Per Share in Cash
-
BrightSpring Health Services, Inc. Welcomes Dr. Nigam H. Shah to Board of Directors
-
UniFirst Shareholders Approve Transaction with Cintas
-
Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform
-
Recludix Pharma to Present Preclinical Asthma and Dermatitis Data for Oral STAT6 Inhibitor REX-8756 at the European Association of Allergy and Clinical Immunology (EAACI) and Revolutionizing Atopic De
-
PTOP Expands Into Construction Sector While Showcasing New MOBICARD(TM) Enterprise Advertising Platform with Addition of Santana Construction Services LLC
-
Revolve Closes Acquisition of Three-Project, 125 MW US Development-Stage Solar Portfolio
-
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight
-
What Happens After You Owe the IRS? Clear Start Tax Shares Its Client Resolution Data and the Programs Behind the Outcomes
-
Composition of Sanoma’s Shareholders’ Nomination Committee
-
Willow Laboratories Welcomes Dr. Jill Biden, Ken Buck, and Said Hilal to Willow's Board of Directors
-
Infection-control readiness cannot wait for crisis, warns Hydrachem after Ebola response supply work
-
Form 8.3 - Picton Property Income Limited
-
Form 8.3 - LondonMetric Property Plc & Schroder REIT Ltd
-
Property Worx Offers GTA Homeowners Single POC for Entire Restoration Process
